Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

NCT00612742 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3656

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG: testosterone gel
DRUG: placebo gel

Sponsor

BioSante Pharmaceuticals